Objective: Currently, no evidence-based guidelines exist for the management of serotonin
reuptake inhibitor (SRI) discontinuation syndrome. This article summarizes …

Use of antidepressants has recently increased, mainly caused by the increase of long-term
users. Although evidence-based indications for long-term use are lacking, it is assumed that …

Antidepressants (ADs) are commonly used for the treatment of various psychological and
other medical disorders. Patient response and regimen duration with individual agents …

Sudden or tapered withdrawal from treatment with antidepressants, including monoamine
oxidase inhibitors (MAOIs), tricyclic antidepressants (TCAs), and serotonin selective …

Introduction: When antidepressants are discontinued, severe withdrawal symptoms are
possible. Some patients have few or no problems stopping, whereas others struggle. That …

The value of a prospective assessment of discontinuation-emergent symptoms proximal to
the termination of antidepressant treatment cannot be overstated. Though varying in …

Data on discontinuation phenomena associated with serotonin selective reuptake inhibitors
(SSRIs) are derived primarily from (1) published case reports,(2) data bases of adverse drug …

Objective Clinical trials and epidemiological studies have shown that premature
discontinuation is a major problem during antidepressant therapy. Unfortunately, there is …

Background: The discontinuation of many pharmacologic agents is associated with
characteristic withdrawal symptoms. Antidepressants, particularly the tricyclic …

Antidepressant Discontinuation Syndrome | AAFP Advertisement search close brand logo
CHRISTOPHER H. WARNER, MAJ, MC, USA, WILLIAM BOBO, LCDR, MC, USN …